RTSN insider trading
Retension Pharmaceuticals, Inc.
In the past 36 days, 2 insiders bought $370K of Retension Pharmaceuticals, Inc. stock in 2 open-market purchases. The largest purchase was $250K by Eric L. Keller (CHIEF EXECUTIVE OFFICER) on Oct 13, 2026.
Insider purchases
| Insider | Value | Holdings | Signal | Traded / filed |
|---|---|---|---|---|
Eric L. Keller CHIEF EXECUTIVE OFFICER |
$250K 20,800 sh @ $12.00 |
+5.2% | Low
|
Oct 13, 2026 Filed Oct 13, 2026 |
Franklin M Berger Director |
$120K 10,000 sh @ $12.00 |
New position | Medium
|
Oct 13, 2026 Filed Oct 13, 2026 |
Insider sales
No open-market sales by insiders in this period.